We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Show more
Period β | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.011 | -3.59477124183 | 0.306 | 0.4 | 0.29 | 1051244 | 0.32627113 | CS |
4 | -0.5276 | -64.1380987114 | 0.8226 | 0.89 | 0.29 | 323550 | 0.4580386 | CS |
12 | -0.6315 | -68.1597409606 | 0.9265 | 1.38 | 0.29 | 890160 | 0.9667553 | CS |
26 | -7.603 | -96.2648771841 | 7.898 | 10.8 | 0.29 | 657256 | 2.68112819 | CS |
52 | -62.185 | -99.5278489117 | 62.48 | 80.96 | 0.29 | 556604 | 9.57797654 | CS |
156 | -940.425 | -99.9686410409 | 940.72 | 989.9956 | 0.29 | 586664 | 379.12907067 | CS |
260 | -37.765 | -99.2249080399 | 38.06 | 2640 | 0.29 | 571712 | 416.00396729 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions